Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the current ratio high or low?
The current ratio of 1.13 is 33% below its 5-year average of 1.68, near the low end of its 5-year range (1.13–2.70).
As of the fiscal period ended Tuesday, June 30, 2026. 8.34% below its 12-month average of 1.23.
Reported quarterly current ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 1.13.
CURRENT RATIO
1.13
CURRENT RATIO AVG TTM
1.23
CURRENT RATIO AVG 3Y
1.26
CURRENT RATIO AVG 5Y
1.68
CURRENT RATIO AVG 10Y
1.50
CURRENT RATIO AVG 15Y
N/A
CURRENT RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-8.34%
CURRENT VS 3Y AVG
-10.88%
CURRENT VS 5Y AVG
-32.84%
CURRENT VS 10Y AVG
-24.76%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.76
median of 873 covered companies
CURRENT VS SECTOR MEDIAN
-70.03%
vs the sector median at left
Market Cap
$355.43M
Current Ratio
24.16
TTM Avg
12.00
3Y Avg
8.65
5Y Avg
7.93
Market Cap
$353.88M
Current Ratio
3.76
TTM Avg
4.71
3Y Avg
6.65
5Y Avg
8.92
Market Cap
$359.53M
Current Ratio
5.85
TTM Avg
6.36
3Y Avg
5.52
5Y Avg
8.17
Market Cap
$349.70M
Current Ratio
8.26
TTM Avg
5.36
3Y Avg
5.81
5Y Avg
4.44
| NAME | MARKET CAP | CURRENT RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Viemed Healthcare, Inc. (VMD) | $355.36M | 1.13 | 1.23 | 1.26 | 1.68 |
| Artiva Biotherapeutics, Inc. (ARTV)vs › | $355.43M | 24.16 | 12.00 | 8.65 | 7.93 |
| Enanta Pharmaceuticals, Inc. (ENTA)vs › | $353.88M | 3.76 | 4.71 | 6.65 | 8.92 |
| Embecta Corp. (EMBC)vs › | $353.00M | 1.68 | 2.22 | 2.19 | 2.04 |
| Ocugen, Inc. (OCGN)vs › | $352.67M | 0.80 | 1.96 | 2.47 | 5.28 |
| Fennec Pharmaceuticals Inc. (FENC)vs › | $359.53M | 5.85 | 6.36 | 5.52 | 8.17 |
| Orchestra BioMed Holdings, Inc. (OBIO)vs › | $349.70M | 8.26 | 5.36 | 5.81 | 4.44 |
| Opus Genetics, Inc. (IRD)vs › | $361.64M | 12.19 | 4.83 | 10.20 | 8.85 |
| Turn Therapeutics Inc. (TTRX)vs › | $346.73M | 1.19 | 1.21 | 1.62 | 1.62 |
| Relmada Therapeutics, Inc. (RLMD)vs › | $344.04M | 29.52 | 9.54 | 9.83 | 10.59 |
Current Ratio
1.13
Quick Ratio
1.02
Current Ratio = Current Assets / Current Liabilities
The current ratio measures short-term liquidity — a company's ability to cover current liabilities with current assets. Above 1.0 indicates positive working capital.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | CURRENT RATIO |
|---|---|
| 2026-06-30 | 1.13 |
| 2026-03-31 | 1.22 |
| 2025-12-31 | 1.18 |
| 2025-09-30 | 1.13 |
| 2025-06-30 | 1.48 |
| 2025-03-31 | 1.38 |
| 2024-12-31 | 1.42 |
| 2024-09-30 | 1.31 |
| 2024-06-30 | 1.43 |
| 2024-03-31 | 1.28 |
| 2023-12-31 | 1.19 |
| 2023-09-30 | 1.14 |
| 2023-06-30 | 1.14 |
| 2023-03-31 | 1.99 |
| 2022-12-31 | 2.11 |
| 2022-09-30 | 2.09 |
| 2022-06-30 | 2.34 |
| 2022-03-31 | 2.70 |
| 2021-12-31 | 2.66 |
| 2021-09-30 | 2.34 |
| 2021-06-30 | 2.57 |
| 2021-03-31 | 2.21 |
| 2020-12-31 | 2.05 |
| 2020-09-30 | 1.65 |
| 2020-06-30 | 1.55 |
| 2020-03-31 | 1.15 |
| 2019-12-31 | 1.07 |
| 2019-09-30 | 1.19 |
| 2019-06-30 | 1.04 |
| 2019-03-31 | 1.25 |
| 2018-12-31 | 1.18 |
| 2018-09-30 | 1.49 |
| 2018-06-30 | 1.43 |
| 2018-03-31 | 1.41 |
| 2017-12-31 | 1.29 |
| 2017-09-30 | 1.35 |
| 2017-06-30 | 0.00 |
| 2017-03-31 | 0.00 |
| 2016-12-31 | 1.22 |
| 2016-09-30 | 0.00 |
